Saxon Interests Inc. Has $1.08 Million Holdings in CME Group Inc. (NASDAQ:CME)

Saxon Interests Inc. increased its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 10.1% during the first quarter, HoldingsChannel reports. The fund owned 5,009 shares of the financial services provider’s stock after acquiring an additional 459 shares during the quarter. Saxon Interests Inc.’s holdings in CME Group were worth $1,078,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Mutual Advisors LLC purchased a new stake in shares of CME Group in the third quarter valued at about $206,000. Truist Financial Corp boosted its stake in shares of CME Group by 15.9% in the 3rd quarter. Truist Financial Corp now owns 82,384 shares of the financial services provider’s stock worth $16,495,000 after buying an additional 11,307 shares during the last quarter. Glenmede Trust Co. NA grew its holdings in shares of CME Group by 2.3% in the third quarter. Glenmede Trust Co. NA now owns 119,584 shares of the financial services provider’s stock valued at $23,943,000 after acquiring an additional 2,726 shares in the last quarter. Shelton Capital Management grew its holdings in shares of CME Group by 522.2% in the third quarter. Shelton Capital Management now owns 14,179 shares of the financial services provider’s stock valued at $2,839,000 after acquiring an additional 11,900 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of CME Group by 3.6% during the third quarter. Ameriprise Financial Inc. now owns 3,579,057 shares of the financial services provider’s stock valued at $716,604,000 after acquiring an additional 125,263 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CME. Morgan Stanley boosted their price target on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 9th. Barclays lifted their price target on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a report on Thursday, April 25th. JPMorgan Chase & Co. downgraded CME Group from a “neutral” rating to an “underweight” rating and decreased their target price for the stock from $206.00 to $187.00 in a research report on Friday, June 21st. Bank of America upped their price target on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. Finally, Keefe, Bruyette & Woods boosted their price objective on CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday, April 25th. Three analysts have rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $215.90.

View Our Latest Research Report on CME

Insider Buying and Selling

In other news, Director Elizabeth A. Cook sold 1,000 shares of the business’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $211.52, for a total transaction of $211,520.00. Following the completion of the transaction, the director now owns 18,241 shares of the company’s stock, valued at $3,858,336.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other CME Group news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elizabeth A. Cook sold 1,000 shares of the company’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $211.52, for a total value of $211,520.00. Following the completion of the transaction, the director now owns 18,241 shares of the company’s stock, valued at $3,858,336.32. The disclosure for this sale can be found here. Insiders sold a total of 54,290 shares of company stock worth $11,393,700 over the last ninety days. 0.30% of the stock is owned by corporate insiders.

CME Group Price Performance

Shares of CME traded up $1.58 during midday trading on Tuesday, hitting $197.08. 4,672,405 shares of the company traded hands, compared to its average volume of 1,924,631. The stock has a 50-day moving average of $204.90 and a 200-day moving average of $208.48. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. CME Group Inc. has a one year low of $180.11 and a one year high of $223.80. The firm has a market cap of $70.96 billion, a P/E ratio of 22.40, a PEG ratio of 5.18 and a beta of 0.52.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the prior year, the firm posted $2.42 EPS. CME Group’s revenue was up 3.2% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 9.75 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were given a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.33%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.